Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Dr. Reddy's Laboratories arrives at its May 29 earnings release with the same fundamental split that has defined this entire preview cycle — except the short side has just re-escalated sharply.
The borrow market delivered a fresh jolt on Wednesday. Short interest jumped 24.5% in a single session to nearly 19.9 million shares, the largest one-day build of the cycle and the highest absolute level seen across this entire run of previews. That follows a week already up nearly 20%, putting the one-month increase at 33.6%. Availability has recovered to 55.7% from the cycle lows near 31–33% seen last week — loosening meaningfully from the tightest readings — but the jump in shares short means the lending pool is absorbing a fresh wave of demand. Cost to borrow has risen 37.5% over the week to 0.84%, the highest rate of this preview cycle. The ORTEX short score has pushed to 57.3, a new high for the series, up from 55.2 just a week ago.
Options traders are reading none of it. The put/call ratio held at 0.15 on Thursday — essentially unmoved from the 0.14–0.15 range that has anchored options flow since mid-May. That reading is less than half the 20-day average of 0.40, and call demand continues to dominate by a wide margin. The contrast with the PCR readings above 1.10 from early May remains stark. The two camps — aggressive short-side building in the lending market versus persistent call-dominated options flow — have refused to converge across ten days of previews. They remain equally dug in heading into the print.
The broader context adds nuance. The stock has drifted lower, down 3.2% over the past month to $13.52, with a modest 0.4% slip on Thursday. Analyst data is too stale to be actionable — the most recent changes are from mid-2025 at the earliest, and the consensus price target reflects a different listing currency entirely. What is visible on the institutional side is a broad-based holder list anchored by Indian promoters and large domestic asset managers, with BlackRock adding roughly 1.3 million shares as of April 30. The factor score picture flags a strong dividend score (90th percentile) but a weak EPS surprise rank (12th percentile) — the latter consistent with the recent notes describing flat revenue growth and contracted margins.
Today's print is therefore a test of which camp has read the fundamentals more accurately: whether the call-heavy options flow signals genuine confidence in a margin or revenue beat, or whether the accelerating short build — now at its most aggressive point of the entire cycle — reflects better-informed conviction about the difficulty of the print.
See the live data behind this article on ORTEX.
Open RDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
